)
Yan Zhi
Director, S&I Lead (Recombinant),
CSL Behring
Yan Zhi Ph.D. is Director, S&I Lead (Recombinant) at CSL Behring. She has spent over 15 years in contract testing and manufacturing organizations to support recombinant and gene therapy products development and testing. Since 2020, she has worked in biotechnology field to develop CMC strategy for IND submission of an AAV-based gene therapy product and then to function as CMC / S&I lead for commercial manufacturing; life cycle management, and market expansion of Hemgenix.
Sessions